Loading insider details...
Beta
Latest Form 4 (May 1, 2026): Grant/Award of 48,800 ALT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 1, 2026 | Altimmune, Inc. (ALT) | Grant/Award | 48,800 | n/a |
| Jan 8, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 2,493 | $26.0K |
| Jan 5, 2026 | Altimmune, Inc. (ALT) | Purchase | 500 | $2.1K |
| Sep 29, 2025 | Altimmune, Inc. (ALT) | Grant/Award | 48,800 | n/a |
| Sep 24, 2025 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 18,000 | n/a |
| Mar 18, 2025 | Altimmune, Inc. (ALT) | Purchase | 1,000 | $5.8K |
| Feb 7, 2025 | Altimmune, Inc. (ALT) | Grant/Award | 18,600 | n/a |
| Sep 30, 2024 | Altimmune, Inc. (ALT) | Grant/Award | 34,900 | n/a |
| Sep 29, 2023 | Altimmune, Inc. (ALT) | Grant/Award | 26,100 | n/a |
| Aug 15, 2023 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 3,075 | n/a |